On the recordJune 22, 2023
I ask unanimous consent that the Senate proceed to the immediate consideration of H.R. 1734, which was received from the House. The PRESIDING OFFICER. The clerk will report the bill by title. The senior assistant legislative clerk read as follows: A bill (H.R. 1734) to require coordinated National Institute of Standards and Technology science and research activities regarding illicit drugs containing xylazine, novel synthetic opioids, and other substances of concern, and for other purposes. There being no objection, the Senate proceeded to consider the bill.





